GO:0051970 negative regulation of transmission of nerve impulse: Synaptic Brake Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051970 describes any process that stops, prevents, or reduces the frequency, rate or extent of nerve impulse transmission, the sequential electrochemical polarization and depolarization that travels across a neuron membrane in response to stimulation.
• Negative regulation of neurotransmission is essential for preventing runaway excitation and is achieved through presynaptic, postsynaptic, and network-level mechanisms [1, 7].
• Key molecular players include GABA-A receptor-associated proteins such as Clptm1, synaptic vesicle endocytosis machinery, and allosteric modulators of neurotransmitter receptors [1, 7, 8].
• Dysregulation of this process contributes to Alzheimer's disease, alcohol use disorder, postoperative cognitive dysfunction, and anxiety-related circuit imbalances [3, 4, 5, 6].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of genes that negatively regulate nerve impulse transmission.
• Synapses are the brain's energy-demanding sites, and their inhibitory control is tightly linked to metabolic and cholesterol homeostasis [2, 6].
Description
GO:0051970, negative regulation of transmission of nerve impulse, is a biological process term that captures any mechanism which stops, prevents, or reduces the frequency, rate or extent of nerve impulse transmission. Nerve impulse transmission is the sequential electrochemical polarization and depolarization that travels across the membrane of a neuron in response to stimulation, and its negative regulation is fundamental to information processing, circuit stability, and behavioral control [1, 7]. Without such inhibitory brakes, neural circuits would be prone to runaway excitation, and indeed impaired negative regulation is a common theme in neurological and psychiatric disorders [4, 8].
negative regulation of transmission of nerve impulse At A Glance
| GO ID | GO:0051970 |
|---|---|
| GO term | negative regulation of transmission of nerve impulse |
| Ontology | biological_process |
| Synonym | down regulation of transmission of nerve impulse; down-regulation of transmission of nerve impulse; downregulation of transmission of nerve impulse; inhibition of transmission of nerve impulse; negative regulation of conduction of nerve impulse |
| Major function | Stops, prevents, or reduces the frequency, rate or extent of nerve impulse transmission |
| Related process | Synaptic transmission, synaptic plasticity, neuronal excitability |
| Cellular context | Presynaptic terminals, postsynaptic densities, neuronal membranes |
| Disease relevance | Alzheimer's disease, alcohol use disorder, postoperative cognitive dysfunction, anxiety disorders |
What Is GO:0051970?
In simple terms, GO:0051970 describes the biological brakes that slow down or stop nerve signals. Formally, it encompasses any process that stops, prevents, or reduces the frequency, rate or extent of transmission of a nerve impulse, the sequential electrochemical polarization and depolarization that travels across the membrane of a neuron in response to stimulation. This includes presynaptic mechanisms that limit neurotransmitter release, postsynaptic mechanisms that reduce responsiveness, and network-level inhibitory influences that dampen signal propagation [1, 7].
Why Is negative regulation of transmission of nerve impulse Important in Cell Biology?
Negative regulation of nerve impulse transmission is critical for maintaining the balance between excitation and inhibition in the nervous system. This process prevents excessive neuronal firing that can lead to excitotoxicity, seizures, and cognitive impairment [4, 8]. It is also a key target of pharmacological agents, including allosteric modulators that fine-tune neurotransmission. Understanding the molecular players that mediate this negative regulation provides insight into disease mechanisms and identifies potential therapeutic targets for neurological and psychiatric conditions [3, 6].
• Prevents runaway excitation and excitotoxicity in neural circuits.
• Shapes synaptic plasticity, learning, and memory by gating signal flow.
• Is a primary target of anxiolytic, anesthetic, and anticonvulsant drugs.
• Dysregulation is implicated in Alzheimer's disease and amyloid-beta-induced neuronal dysfunction.
• Chronic alcohol actions on synaptic targets alter inhibitory control of neurotransmission.
• Postoperative cognitive dysfunction involves impaired hippocampal synaptic plasticity and excitatory transmission.
• Cerebello-zona incerta circuits regulate anxiety-like behaviors through plasticity-dependent mechanisms.
• Synaptic vesicle endocytosis acts as a brake on sustained neurotransmission.
• Energy metabolism and cholesterol homeostasis at synapses influence inhibitory control [2, 6].
• CRISPR-based models allow causal dissection of genes that negatively regulate nerve impulse transmission.
What Happens During negative regulation of transmission of nerve impulse?
Presynaptic inhibition of neurotransmitter release
In simple terms: The sending neuron is told to release less chemical messenger.
Presynaptic negative regulation reduces the probability or frequency of synaptic vesicle fusion, thereby lowering the amount of neurotransmitter released per action potential. This can occur through modulation of vesicle priming, calcium influx, or endocytosis machinery. Allosteric modulators can also act presynaptically to dampen release.
Postsynaptic reduction of receptor responsiveness
In simple terms: The receiving neuron becomes less sensitive to the chemical messenger.
Postsynaptic negative regulation involves changes in receptor number, subunit composition, or conductance that reduce the postsynaptic response to neurotransmitter. For example, haploinsufficiency of the GABA-A receptor-associated protein Clptm1 enhances inhibitory neurotransmission, indicating that Clptm1 normally constrains inhibitory signaling.
Synaptic vesicle endocytosis as a brake
In simple terms: Recycling of vesicle membrane puts a limit on how much transmitter can be released.
Synaptic vesicle endocytosis retrieves membrane and proteins after fusion, and its regulation can put a brake on sustained neurotransmission. Proteins that control endocytosis thus negatively regulate the transmission of nerve impulses by limiting the available pool of synaptic vesicles.
Network-level inhibitory gating
In simple terms: Whole circuits can be turned down by inhibitory neurons.
At the circuit level, inhibitory interneurons and pathways such as cerebello-zona incerta circuits provide negative regulation of nerve impulse transmission, influencing behaviors like anxiety. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease disrupts network-level inhibitory control.
Metabolic and lipid constraints on synaptic transmission
In simple terms: Energy and cholesterol supply can limit how much signaling occurs.
Synapses are energy-demanding sites, and metabolic or cholesterol deficiencies can impair synaptic plasticity and excitatory synaptic transmission [2, 6]. Astrocytic SREBP2 downregulation leads to neuronal cholesterol deficiency, which impairs hippocampal synaptic plasticity and excitatory synaptic transmission, effectively reducing nerve impulse transmission.
Key Genes Involved in GO:0051970 negative regulation of transmission of nerve impulse
The following genes and proteins are experimentally implicated in negative regulation of transmission of nerve impulse, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CLPTM1 | GABA-A receptor-associated protein; haploinsufficiency enhances inhibitory neurotransmission | Regulates inhibitory synapse strength; KO models show enhanced phasic and tonic inhibition |
| GABRA1 | GABA-A receptor subunit; mediates inhibitory postsynaptic currents | Target for allosteric modulators that negatively regulate neurotransmission |
| GABRB2 | GABA-A receptor subunit; contributes to inhibitory tone | Mutations alter inhibitory control and network excitability |
| SREBP2 | Astrocytic transcription factor controlling cholesterol synthesis | Downregulation causes neuronal cholesterol deficiency and impaired synaptic transmission |
| APOE | Lipid transport protein; influences synaptic cholesterol homeostasis | Linked to Alzheimer's disease and synaptic dysfunction |
| APP | Amyloid precursor protein; source of amyloid-beta | Amyloid-beta induces neuronal dysfunction and disrupts network activity |
| DNM1 | Dynamin 1; mediates synaptic vesicle endocytosis | Endocytosis brake on sustained neurotransmission |
| CLTC | Clathrin heavy chain; vesicle coat protein | Required for synaptic vesicle recycling and negative regulation of release |
| AP2M1 | AP-2 complex subunit; endocytic adaptor | Regulates vesicle endocytosis and transmitter release |
| SYN1 | Synapsin I; tethers vesicles to actin | Modulates vesicle availability and neurotransmitter release |
| GAD1 | Glutamate decarboxylase; synthesizes GABA | Determines inhibitory tone in circuits |
| GAD2 | Glutamate decarboxylase; synthesizes GABA | Determines inhibitory tone in circuits |
| SLC6A1 | GAT1 GABA transporter; clears synaptic GABA | Regulates inhibitory transmission duration |
| SLC32A1 | VGAT; loads GABA into vesicles | Controls inhibitory vesicle content |
| GRIA1 | AMPA receptor subunit; mediates excitatory transmission | Modulated to reduce excitatory drive |
| GRIN1 | NMDA receptor subunit; mediates excitatory transmission | Target of negative regulation in plasticity |
| KCNQ2 | Potassium channel; M-current dampens excitability | Mutations cause hyperexcitability; negative regulator of impulse transmission |
| SCN1A | Sodium channel; action potential initiation | Reduced function lowers excitability and impulse transmission |
How Is negative regulation of transmission of nerve impulse Regulated?
Negative regulation of nerve impulse transmission is itself regulated at multiple levels. Allosteric modulators can bind neurotransmitter receptors to enhance or dampen signaling. Synaptic vesicle endocytosis is controlled by phosphorylation and protein-protein interactions that determine the rate of membrane retrieval. Metabolic signals, including cholesterol availability via astrocytic SREBP2, can constrain synaptic plasticity and excitatory transmission. Additionally, chronic alcohol exposure alters synaptic targets, shifting the balance of inhibitory and excitatory control.
negative regulation of transmission of nerve impulse and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CLPTM1 | Memory impairment and inhibitory neurotransmission imbalance | Clptm1 knockout and haploinsufficient knock-in mice |
| APP | Alzheimer's disease; amyloid-beta-induced neuronal dysfunction | APP knock-in and overexpression models |
| SREBP2 | Postoperative cognitive dysfunction; cholesterol deficiency | Astrocyte-specific SREBP2 knockout mice |
| GABRA1 | Epilepsy and anxiety; inhibitory tone dysregulation | Point-mutation knock-in mice |
| DNM1 | Developmental and epileptic encephalopathy; endocytosis defects | Dnm1 knockout and point-mutation models |
Alzheimer's disease and amyloid-beta-induced neuronal dysfunction
Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease disrupts synaptic transmission and network activity, in part by impairing negative regulatory mechanisms that normally keep circuits stable. Synaptic cholesterol homeostasis and APOE-related pathways further modulate this vulnerability [4, 6].
Alcohol use disorder and synaptic targets
Chronic alcohol actions on synaptic targets alter both excitatory and inhibitory neurotransmission, leading to maladaptive changes in the negative regulation of nerve impulse transmission. These changes contribute to tolerance, dependence, and withdrawal hyperexcitability.
Postoperative cognitive dysfunction
Neuronal cholesterol deficiency mediated by astrocytic SREBP2 downregulation leads to postoperative cognitive dysfunction through impairment of hippocampal synaptic plasticity and excitatory synaptic transmission. This highlights how metabolic regulation of synapses intersects with negative control of nerve impulse transmission.
Anxiety and circuit-level inhibitory imbalance
Dual and plasticity-dependent regulation of cerebello-zona incerta circuits on anxiety-like behaviors demonstrates that negative regulation of nerve impulse transmission at the circuit level can shape emotional behavior. Disruption of these inhibitory controls may contribute to anxiety disorders.
From negative regulation of transmission of nerve impulse-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene enhance nerve impulse transmission? | CRISPR knockout in primary neurons or iPSC-derived neurons |
| Does a specific point mutation alter inhibitory receptor function? | CRISPR point-mutation knock-in in cell lines or mice |
| Does overexpression of an endocytosis protein reduce transmitter release? | CRISPR overexpression (safe-harbor knock-in) in neurons |
| How does a tagged protein localize at synapses? | Tagged knock-in (e.g., GFP) for imaging |
| Does astrocytic cholesterol deficiency impair synaptic transmission? | Conditional knockout of SREBP2 in astrocytes |
| Can circuit-level inhibition be manipulated to alter anxiety? | Optogenetic or chemogenetic modulation in circuit-specific Cre lines |
How to Study the negative regulation of transmission of nerve impulse Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Postsynaptic current amplitude and frequency | Quantify inhibitory vs excitatory transmission |
| Field potential recording | Network excitability and synaptic plasticity | Assess hippocampal LTP/LTD |
| Live-cell imaging | Vesicle exocytosis and endocytosis rates | Presynaptic brake mechanisms |
| RNA-seq | Transcriptional changes in synaptic genes | Identify compensatory pathways |
| Proteomics | Protein abundance and interactions at synapses | Map endocytic machinery |
| Behavioral testing | Memory, anxiety, alcohol response | Link molecular changes to behavior [3, 5] |
| Immunohistochemistry | Synaptic protein localization | Validate receptor and scaffold distribution |
Electrophysiology
Patch-clamp recordings measure miniature excitatory and inhibitory postsynaptic currents (mEPSCs/mIPSCs) to quantify changes in nerve impulse transmission and its negative regulation. Field recordings in slices assess network excitability and plasticity.
Imaging of synaptic vesicle dynamics
Live-cell imaging with pH-sensitive or fluorescent vesicle markers tracks exocytosis and endocytosis, revealing presynaptic brakes on neurotransmission. Super-resolution microscopy can localize receptors and scaffolding proteins at synapses.
Transcriptomics and proteomics
RNA-seq and proteomics identify changes in gene expression and protein abundance following manipulation of negative regulators, such as Clptm1 or SREBP2 [6, 8]. These approaches can uncover compensatory adaptations in synaptic pathways.
Behavioral assays
Behavioral tests for memory, anxiety, and alcohol response link molecular changes in negative regulation of nerve impulse transmission to organism-level phenotypes [3, 5, 8].
How CRISPR Can Be Used to Study GO:0051970 negative regulation of transmission of nerve impulse
Knockout
CRISPR knockout of genes such as CLPTM1 or DNM1 in neurons or cell lines can test whether loss of function enhances or reduces nerve impulse transmission. For example, Clptm1 haploinsufficiency enhances phasic and tonic inhibitory neurotransmission, demonstrating its role as a negative regulator.
Point Mutation
CRISPR point-mutation knock-in can model disease-associated variants in receptors or channels, such as GABRA1 or SCN1A, to determine how specific residues affect inhibitory control of neurotransmission.
Knock-in
Knock-in of tags or reporters (e.g., GFP) at endogenous loci allows visualization of synaptic proteins and their dynamics in live neurons, providing insight into negative regulation of transmission.
Overexpression
CRISPR-mediated overexpression via safe-harbor integration can test whether increasing levels of an endocytic protein or receptor subunit strengthens the brake on nerve impulse transmission.
How EDITGENE Supports negative regulation of transmission of nerve impulse Research
Researchers studying negative regulation of transmission of nerve impulse-related genes often need to determine whether a candidate gene is causally involved in dampening neuronal signaling or is merely correlated with changes in synaptic activity. EDITGENE provides the CRISPR tools and services to move from correlation to causation in relevant neuronal and non-neuronal models.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of transmission of nerve impulse research.
Frequently Asked Questions About negative regulation of transmission of nerve impulse
What is GO:0051970?
GO:0051970 is the Gene Ontology term for negative regulation of transmission of nerve impulse, defined as any process that stops, prevents, or reduces the frequency, rate or extent of nerve impulse transmission.
What genes are involved in negative regulation of transmission of nerve impulse?
Genes include CLPTM1, GABRA1, GABRB2, DNM1, CLTC, AP2M1, SYN1, GAD1, GAD2, SLC6A1, SLC32A1, GRIA1, GRIN1, KCNQ2, and SCN1A, among others [1, 7, 8].
How is nerve impulse transmission negatively regulated?
It is negatively regulated by presynaptic mechanisms that reduce neurotransmitter release, postsynaptic changes that lower receptor responsiveness, endocytic brakes on vesicle recycling, and network-level inhibitory gating [1, 7, 8].
What diseases are linked to impaired negative regulation of neurotransmission?
Alzheimer's disease, alcohol use disorder, postoperative cognitive dysfunction, and anxiety disorders have been linked to disrupted negative regulation of nerve impulse transmission [3, 4, 5, 6].
What is the role of CLPTM1 in neurotransmission?
CLPTM1 is a GABA-A receptor-associated protein whose haploinsufficiency enhances phasic and tonic inhibitory neurotransmission, suppresses excitatory synaptic plasticity, and impairs memory.
How do synapses act as brakes on nerve impulses?
Synapses can act as brakes through endocytosis of vesicle membrane, desensitization of receptors, and inhibitory interneuron activity that dampens circuit excitability [7, 5].
Can CRISPR be used to study negative regulation of nerve impulse transmission?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes involved in this process.
What methods measure negative regulation of nerve impulse transmission?
Patch-clamp electrophysiology, field recordings, live-cell imaging of vesicle dynamics, RNA-seq, proteomics, and behavioral assays are commonly used [6, 7, 8].
What is the role of cholesterol in synaptic transmission?
Neuronal cholesterol deficiency mediated by astrocytic SREBP2 downregulation impairs hippocampal synaptic plasticity and excitatory synaptic transmission.
How does alcohol affect negative regulation of neurotransmission?
Chronic alcohol actions on synaptic targets alter inhibitory and excitatory neurotransmission, disrupting the normal negative regulation of nerve impulse transmission.
Conclusion
GO:0051970, negative regulation of transmission of nerve impulse, is a fundamental biological process that keeps neural circuits stable and responsive. Its molecular underpinnings involve presynaptic, postsynaptic, and network-level mechanisms, with key roles for proteins such as CLPTM1, endocytic machinery, and metabolic regulators like SREBP2 [6, 7, 8]. Dysregulation of this process is implicated in Alzheimer's disease, alcohol use disorder, postoperative cognitive dysfunction, and anxiety, making it a rich area for therapeutic targeting [3, 4, 5]. CRISPR-based models and advanced imaging and electrophysiology methods provide powerful tools to dissect these mechanisms and identify new interventions.
References
- 1. Kenakin T. 2025. Allosteric modulation of neurotransmission.. Biochem Pharmacol 239:117026 PMID: 40513992
- 2. Faria-Pereira A et al.. 2022. Synapses: The Brain's Energy-Demanding Sites.. Int J Mol Sci 23(7) PMID: 35408993
- 3. Roberto M et al.. 2017. Synaptic targets: Chronic alcohol actions.. Neuropharmacology 122:85-99 PMID: 28108359
- 4. Palop JJ et al.. 2010. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks.. Nat Neurosci 13(7):812-8 PMID: 20581818
- 5. Zhao Y et al.. 2025. Dual and plasticity-dependent regulation of cerebello-zona incerta circuits on anxiety-like behaviors.. Nat Commun 16(1):3339 PMID: 40199879
- 6. Huang H et al.. 2026. Neuronal Cholesterol Deficiency Mediated by Astrocytic SREBP2 Downregulation Leads to Postoperative Cognitive Dysfunction Through Impairment of Hippocampal Synaptic Plasticity and Excitatory Synaptic Transmission.. Adv Sci (Weinh) 13(23):e19874 PMID: 41674341
- 7. Wang YL et al.. 2017. Putting a brake on synaptic vesicle endocytosis.. Cell Mol Life Sci 74(16):2917-2927 PMID: 28361181
- 8. Ge Y et al.. 2024. Haploinsufficiency of GABA(A) Receptor-Associated Clptm1 Enhances Phasic and Tonic Inhibitory Neurotransmission, Suppresses Excitatory Synaptic Plasticity, and Impairs Memory.. J Neurosci 44(32) PMID: 38942471
